FDA Approves Drug for Pancreatic Cancer Treatment
Olaparib is already approved for use in BRCA-mutated ovarian and breast cancers.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Health | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer